You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back

Relvar Ellipta contains two medicines, fluticasone furoate and vilanterol. Relvar Ellipta is a long-acting bronchodilator combined with an inhaled corticosteroid that is taken once daily for the treatment of asthma and COPD.*

* Relvar Ellipta is indicated for the regular treatment of asthma and COPD. (Asthma - in adults and adolescents aged 12 years and older; COPD - in adults; please refer to PIL and SPC links above for further information)

Relvar and Ellipta are registered trademarks of the GlaxoSmithKline Group of Companies